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We compared several alternative ECL solutions for Western blot detection of endogenous proteins in whole cell lysates using
inexpensive, commercially available reagents. Starting from an existing protocol based on p-coumaric acid (pCA) as enhancer, we
found that the ECL solution containing 4-iodophenylboronic acid (4IPBA) generated strong specific signals and low background
chemiluminescence. We optimised the luminol, 4IPBA and hydrogenperoxide concentrations of this 4IPBA–ECL solution. The
optimised 4IPBA–ECL solution (100 mM Tris/HCl pH 8.8, 1.25 mM luminol, 2 mM 4IPBA, 5.3 mM hydrogenperoxide) shows a
greatly increased signal intensity compared to the initial pCA–ECL protocol and to some commercially available ECL solutions. In
addition, the optimised 4IPBA–ECL solution also generates much lower background chemiluminescence than other non-
commercial ECL solutions using p-coumaric acid or 4-iodophenol as enhancers. The 4IPBA–ECL solution was stable when stored
but had the lowest background when prepared freshly from stock solutions. Thus, we present an optimised protocol for a well-
performing inexpensive ECL solution which is an alternative to expensive commercial ECL solutions and which achieves a better
signal and lower background than the commercial solutions tested.
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The horseradish peroxidase (HRP)-catalysed en-
hanced chemiluminescence is widely used in basicAbbreviations: 4IPBA, 4-iodophenylboronic acid; pCA, para-
coumaric acid; 4IP, 4-iodophenol; ECL, enhanced chemilumines-
cence; HRP, horseradish peroxidase; Jak, Janus kinase; STAT, signal
transducer and activator of transcription; BSA, bovine serum
albumine; ICAM, intercellular adhesion molecule.
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doi:10.1016/j.jim.2006.07.027research and has found its application in many
commercial kits. One important application in life
sciences is the ECL detection of Western blots. Proteins
on Western blots are recognised by specific primary
antibodies which are in turn detected by a secondary
antibody coupled to HRP. HRP catalyzes the oxidation
of luminol or other substrates in the presence of
peroxidase and an enhancer. The light output is detected
on film or by CCD camera-equipped documentation
systems. The ECL detection has several advantages
compared to colorimetric detection ofWestern blots. It is
more sensitive and the blots can be reprobed with other
primary antibodies after stripping of the membrane.
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coumaric acid, phenolic compounds, phenylboronic
acid derivatives and others) can be used to enhance
the light emission from the decay of the aminophtalate
dianion, generated by the oxidation of luminol (Thorpe
et al., 1985; Kricka et al., 1996b; Kuroda et al., 1999;
Rehm, 2002). Different boronic acid derivatives were
used as enhancer in the ECL detection of proteins on dot
blots and Western blots with purified proteins but not
with the aim of detecting endogenous amounts of
proteins in Western blots of whole-cell lysates (Kricka
et al., 1996a; Kuroda et al., 2001).
Here we compared alternative ECL solutions con-
taining the different enhancers p-coumaric acid (pCA),
4-iodophenylboronic acid (4IPBA) or 4-iodophenol
(4IP), to commercial ECL solutions. We were interested
in obtaining a solution which would work well in
detection of Western blots of total cell lysates, a
situation in which the major problem is often not the
detection limit but unspecific background chemilumi-
nescence which can be due e.g. to unspecific primary
and secondary antibody binding. The chemicals we used
for the alternative ECL solutions are commercially
available and inexpensive. We found that 4IPBA–ECL
showed a very low background chemiluminescence
allowing much longer exposure times than the other
tested ECL solutions. We optimised the 4IPBA–ECL
solution so that the signal intensity was superior to that
of commercial kits and a previously described non-
commercial ECL solution (Rehm, 2002).
2. Materials and methods
2.1. The alternative, non-commercial ECL solutions
DMSO stock solutions of 250 mM luminol (Aldrich),
90 mM para-coumaric acid (pCA) (Sigma), 90 mM 4-
iodophenylboronic acid (4IPBA) (Aldrich) and 90 mM 4-
iodophenol (4IP) (Aldrich) were prepared. The ECL
solutions were generated by diluting luminol and one of
the enhancers (pCA, 4IPBA or 4IP) in 100 mM Tris/HCl
pH 8.8. Hydrogenperoxyde (from a 30% stock solution)
was added freshly to the ECL solutions just before
detection of the membranes. The concentration of the
enhancers (pCA, 4IPBA or 4IP), luminol and hydro-
genperoxidewere varied as described in the figure legends.
The composition of the initial ECL solutions used to
compare pCA and 4IPBA was as follows: 100 mM Tris/
HCl pH 8.8, 2.5 mM luminol, 0.4 mM pCA or 4IPBA,
2.6 mM hydrogenperoxide. The optimised 4IPBA–ECL-
solution contains 100 mM Tris/HCl pH 8.8, 1.25 mM
luminol, 2 mM 4IPBA, 5.3 mM hydrogenperoxide.2.2. ECL detection in 96 well plates
Each well contained a final volume of 100 μl solution
with a final concentration of 2.5 mM luminol. The HRP-
coupled antibody from Dako was used in a dilution of
1:1000. The concentration of the enhancers was varied
as stated in the figure legend. To start the reaction,
hydrogenperoxide was added to a final concentration of
2.6 mM. Chemiluminescence was observed using the
CCD camera-equipped Chemi Lux detection system by
Intas.
2.3. Cell culture
U4C and 2C4 cells (human fibrosarcoma cells kindly
provided by Dr. I. M. Kerr, Cancer Research UK,
London) were maintained in Dulbecco's modified
Eagle's medium (Gibco) supplemented with 10% fetal
calf serum, 100 mg/l streptomycin, and 60 mg/l penicil-
lin. Cells were grown at 37 °C in a water-saturated
atmosphere at 5% CO2.
2.4. Cell lysis and Western blot analysis
All steps of cell lysis were performed at 4 °C using ice
cold buffers. Cells were lysed on the dish with 500 μl of
lysis buffer containing 1% Triton-X-100, 20 mM Tris/
HCl pH 7.5, 150 mM NaCl, 10 mM NaF, 1 mM sodium
vanadate, 10 mM PMSF, 1 mM benzamidine, 5 μg/ml
aprotinin, 3 μg/ml pepstatin, 5 μg/ml leupeptin and
1 mM EDTA. The cleared lysates were analyzed further
by SDS-PAGE. The proteins were transferred to a
polyvinylidene difluoride membrane (Amersham Phar-
macia Biotech) and probed with the respective anti-
bodies. Anti-Jak1 (610232, Transduction Laboratories),
anti-calnexin (610523, Transduction Laboratories), anti-
STAT-1 (610116, Transduction Laboratories), anti-actin
(MAB1501, Chemicon) and anti-ICAM1 (G5, Santa
Cruz Biotech.) were used for detection. The horseradish
peroxidase-conjugated secondary goat-anti-mouse anti-
body was purchased from Dako (P0447). To ensure
exactly the same treatment of the different blots during
the Western blot detection procedure, multiple samples
of the lysates and the molecular size marker were run on
the same gel. After Western blotting, the uncut blot was
treated with blocking solution (10% BSA, 10 mM Tris/
HCl pH 7.4, 140 mM NaCl, 0.1% NP-40) and then
subsequently with the first and secondary antibody
solutions (antibody diluted in 10 mM Tris/HCl pH 7.4,
140 mM NaCl, 0.1% NP-40). The blot was cut just
before detection with the different ECL solutions. Thus,
only those blots were compared which had been exposed
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antibody-detection conditions. Having 22 slots on one
gel, this limited the number of blots which could be
compared to seven. The blots were always prepared
freshly and were not stripped and reprobed to exclude
effects due to previous detections. Blots were then
incubated with the different ECL solutions. The “ECL-
Western Blotting analysis system” (RPN2108, Amer-
sham Biosciences), further named “commercial ECL-1”
(Com1), and “SuperSignal West Pico chemiluminescent
substrate” (#34080, Pierce), further named “commercial
ECL-2” (Com2), were used according to the manufac-
turers' protocols. The self made ECL solutions, contain-
ing pCA, 4IPBA or 4IP as described above, were
incubated for 1 min with the blots before detection. The
signals were detected either on film (Hyperfilm-ECL,
Amersham Biosciences) or using the Chemi Lux ECLFig. 1. The 4IBPA–ECL solution results in significantly less background che
cells were separated by SDS-PAGE and transferred to PVDF membranes b
antibodies (A) anti-Jak1 (610232, Transduction Laboratories) or (B) anti-ca
Transduction Laboratories). The blots were incubated with the various ECL
Intas. Detection times were chosen so that the signal strength and the different
(short exposure: 1–2 min; long exposure 5–10 min). The self made pCA
hydrogenperoxide and 0.4 mM of either p-coumaric acid or 4-iodophenylboro
the manufacturer's instructions. The position of molecular size markers is indetection system (Intas). All the blots from one
experiment (i.e. from one initial membrane from one
SDS-PAGE gel) were detected at the same time with
enough space in between them to prevent any mixing of
different ECL solutions.
3. Results and discussion
3.1. A 4IBPA–ECL solution combines high sensitivity
and low background for Western blot detection
The major challenge in protein detection on Western
blots of total cell lysates is often not the detection limit
but unspecific signals and background chemilumines-
cence. To distinguish the specific signal of a primary
antibody from unspecific signals and the background we
took advantage of a pair of well-characterizedmiluminescence than the pCA–ECL solution. Lysates of U4C and 2C4
y electroblotting. The Western blots were detected using as primary
lnexin (610523, Transduction Laboratories) and anti-STAT1 (610116,
solutions before detection with the Chemi Lux detection system from
background chemiluminescence of the three solutions became apparent
– and 4IPBA–ECL solutions contained 2.5 mM luminol, 2.6 mM
nic acid. The commercial ECL solution (Com1) was used according to
dicated in (A).
Fig. 2. ECL solutions generate different effects in the Western blot
detection than in the solution assay. (A) Lysates of U4C and 2C4 cells
were separated by SDS-PAGE and transferred to PVDF membranes by
electroblotting. The Western blots were then detected using an anti-
Jak1 primary antibody (610232, Transduction Laboratories). The blots
were incubated for 1 min with the various ECL solutions and then
detected with the Chemi Lux detection system from Intas for identical
intervals (1 min), starting at different time points after the beginning of
the detection, as indicated. The 4IPBA– and the pCA–ECL solutions
were composed as described in the legend of Fig. 1. Triton X-100
(TX100) was added to the 4IPBA–ECL solution to a percentage of
0.25%. (B) The concentration dependancy of pCA and 4IPBA on
chemiluminescence was investigated in a 96 well assay as described in
Materials and methods. Each well contained a final concentration of
2.5 mM luminol and HRP-conjugated secondary antibody in a dilution
of 1:1000. The concentrations of the enhancers p-CA and 4-IPBAwere
varied from 800 μM to 3 μM. To start the reaction, hydrogenperoxide
was added to a final dilution of 2.6 mM. Chemiluminescence was
observed using the Chemi Lux detection system from Intas.
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kinase 1 (Jak1) (Kohlhuber et al., 1997; Behrmann et al.,
2004). Jak1 is a tyrosine kinase crucial for interferon
signal transduction as well as for signalling mediated by
cytokines of the IL-2 and IL-6 families (Yeh and
Pellegrini, 1999; Heinrich et al., 2003). Western blots of
lysates from 2C4 (Jak1-containing cells) and U4C cells
(Jak1-deficient cells) were prepared as described in
Materials and methods. In first experiments we used a
non-commercial ECL solution based on coumaric acid
as enhancer as published by Rehm (2002) (100 mM
Tris/HCl pH 8.8, 2.5 mM luminol, 0.4 mM pCA,
2.6 mM hydrogenperoxide), and compared this to a
solution with 4IPBA as enhancer, also at a 0.4 mM
concentration. Moreover, we included a commercially
available ECL solution into our study.
Both non-commercial ECL solutions (pCA-ECL and
4IPBA–ECL) were superior to the tested commercial
ECL solution “Com1” with regard to signal strength.
The signal intensities of pCA–ECL- and 4IPBA–ECL-
solutions were comparable in a detection with the Jak1
antibody (Fig. 1A). However, upon longer exposure the
background observed in detections with the pCA–ECL
solution was much higher than the one observed with
the 4IPBA–ECL solution (Fig. 1A, lower panel). This
allowed for much longer exposure times when using
the 4IPBA solution. Also the “Com1” solution showed
a higher background than the 4IPBA–ECL solu-
tion (Fig. 1A, lower panel). Also for other primary
antibodies (anti-calnexin, anti-STAT1) the signal inten-
sity of the non-commercial ECL solutions was higher
than for the commercial solution (Fig. 1B).
3.2. The non-commercial ECL solutions show a fast onset
of chemiluminescence and a robust signal over time
A useful Western blot ECL detection reagent has
several other characteristics besides showing a good signal
intensity. The onset of the signal should be rapid. The
duration of the signal should be as long as possible to
achieve a good signal accumulation over time and to offer
a sufficiently broad time window for successive expo-
sures. We measured the chemiluminescence with a CCD
camera-based system for identical intervals of time,
starting at different time points after addition of the ECL
reagents to theWestern blots (1 min to 30min). Both non-
commercial ECL solutions (pCA–ECLand 4IPBA–ECL)
showed a quick onset of chemiluminescence (t=1 min,
Fig. 2A) and the signalwas sustained for 30minminimum
(t=30 min, Fig. 2A). For the whole time period the
background chemiluminescence was higher for the pCA–
ECL solution than for the 4IBPA–ECL solution.3.3. A solution assay is not suited to optimize ECL
conditions for Western blots
To rapidly test concentration dependencies of the
various ECL solution components and other additives
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plate solution assay (see Materials and methods).
Both enhancers showed an important enhancement
over the non-enhanced reaction (data not shown). Upon
variation of the enhancer concentrations between 800 μM
and 3 μM the chemiluminescence was much greater for
4IPBA than for pCA (Fig. 2B) in the 96 well solution
assay. 400 μMwas the optimal concentration. There were
no additive or synergistic effects when both enhancers
were combined; in fact, the chemiluminescence observed
was lower than that observed for 4IPBA alone (Fig. 2B).
However, the strikingly better performance of 4IPBAFig. 3. Optimisation of the 4IPBA–ECL solution for Western blot detection. I
with a Jak1-specific primary antibody, as described in the legend of Fig. 1. T
varied in an attempt to optimise the chemiluminescent signal. Chemilumines
(A) The concentration of 4IPBAwas varied between 0.2 and 4 mM. The conce
(100 mM Tris/HCl pH 8.8, 2.5 mM luminol, 2.6 mM hydrogenperoxide). Th
(A). The signal was detected for identical intervals (1 min) starting at various t
concentrations of luminol (0.62 mM, 1.25 mM, 2.5 mM) were tested while the
The signal was detected for identical intervals (1 min) starting at vario
(D) Hydrogenperoxide concentrations of 2.6 mM, 5.3 mM and 10.6 mM wer
The signal was detected for identical intervals (1 min) starting at various timobserved in the solution assay is in contrast to theWestern
blot results where pCA and 4IPBA displayed a
comparable sensitivity (Figs. 1 and 2A).
We also investigated the effects of a number of
additives. Detergents were described to have positive
effects on the increase of specific light emissions (Iwata
et al., 1995). Different detergents were tested in the 96
well assay. Triton X-100 at concentrations between
0.25% and 0.5% prolonged chemiluminescence in the
solution assay (data not shown) but it delayed the
chemiluminescence in the Western blot detection and
shortened it at later times (Fig. 2A).dentical Western blots of lysates from 2C4 and U4C cells were detected
he concentration of the constituents of the 4IPBA–ECL solution was
cence was observed using the Chemi Lux detection system from Intas.
ntrations of the other components of the ECL solution were unchanged
e signal was detected for 1 min. (B) Blots were treated as described in
ime points after the beginning of the detection, as indicated. (C) Various
other components were 2 mM 4IPBA and 2.6 mM hydrogenperoxide.
us time points after the beginning of the detection, as indicated.
e tested. The solutions also contained 2 mM 4IPBA, 2.5 mM luminol.
e points after the beginning of the detection, as indicated.
Fig. 4. Comparison of 4IBPA and 4-iodophenol (4IP) as enhancers for
Western blot detection. (A) Identical Western blots of lysates from 2C4
and U4C cells were detected with ECL solutions containing 100 mM
Tris/HCl pH 8.8, 2.5 mM luminol, 2.6 mM hydrogenperoxide and
either 0.4 mM 4IPBA or varying concentrations of 4IP (0.05 mM–
0.8 mM). Chemiluminescence was measured for a two minute interval
using the Chemi Lux detection system from Intas. The position of
molecular size markers is indicated. (B) Western blots were detected
with ECL solutions containing 100 mM Tris/HCl pH 8.8, 2.5 mM
luminol, 2.6 mM hydrogenperoxide and either 0.4 mM pCA, 2 mM
4IPBA, 0.4 mM 4IP or 2 mM 4IP. Chemiluminescence was measured
for a two minute interval using the Chemi Lux detection system from
Intas.
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to enhance chemiluminescence in solution assays like
ammoniumpersulfate and m-chloroperbenzoic acid
(Motsenbocker and Kondo, 1994; Yeh and Lin, 2002)
rather worsened Western blot results (data not shown).
Thus, obviously because of the different assay condi-
tions, we could not use the convenient and fast solu-
tion assay for the optimization of the ECL solution in
Western blot detections. Another group encountered
comparable problems and reported that polymers
stabilized the HRP-mediated light emission in solution
but not in a dot blot or microwell immunoassay (Ji and
Kricka, 1996).
3.4. Optimisation of the 4IPBA–ECL solution for
Western blot detection
In an attempt to optimise the solution, we investi-
gated the effect of various 4IPBA concentrations
(0.2 mM, 0.4 mM, 0.8 mM, 2 mM, 4 mM) on signal
intensity. The concentrations of the other components of
the ECL solution were unchanged (100 mM Tris/HCl
pH 8.8, 2.5 mM luminol, 2.6 mM hydrogenperoxide).
As shown in Fig. 3A, the strongest signal was achieved
at a concentration of 2 mM 4IPBA. The signal was
stable over time and could be detected readily also
30 min after the start of the detection (Fig. 3B).
When we tested a number of luminol concentrations
(0.62 mM, 1.25 mM, 2.5 mM) at a 4IPBA concentration
of 2 mM, we found that a concentration of 1.25 mM
generated the strongest signal over time (Fig. 3C).
Finally, we investigated the effect of hydrogenper-
oxide concentrations on signal intensity. It was reported
previously that HRP is inhibited by concentrations of
hydrogenperoxide above 4.4 mM (Ilyina et al., 2000).
On the other hand, it was described that 4-iodophenyl-
boronic acid reacts with hydrogenperoxide to boric
acid and 4-iodophenol (Handley et al., 2004), another
well known enhancer of chemiluminescent reactions
(Thorpe et al., 1985). This happens within minutes after
the addition of hydrogenperoxide. Thus, 4-iodophenol
might be the actual enhancer in this system and not
4-iodophenylboronic acid. Testing different concentra-
tions of hydrogenperoxide (2.6 mM, 5.3 mM, 10.6 mM)
at a 4IPBA concentration of 2 mM, we found that the
chemiluminescence signal intensity was enhanced when
we increased the concentration to 5.3 mM and that the
signal was stronger over time if compared to higher or
lower hydrogenperoxide concentrations. Higher con-
centrations led to a decrease of chemiluminescence with
time while for lower concentrations the chemilumines-
cent signal was delayed (Fig. 3D).3.5. Comparison of 4IBPA and 4-iodophenol (4IP) as
enhancers for Western blot detection
Because 4IPBA was described to quantitatively
react to 4-iodophenol (4IP) and boric acid in the pres-
ence of hydrogenperoxide (Handley et al., 2004) we
now included 4-iodophenol (4IP) into our study. We
analysed if the 4IP- and the 4IPBA–ECL behaved
identically. Testing different concentrations of 4IP in
the ECL solution showed that 4IP was in fact a stronger
enhancer than 4IPBA. At a concentration of 0.2 mM,
4IP led to a signal of comparable intensity as seen for
0.4 mM 4IPBA (Fig. 4A). However, the background
signal was also elevated. Fig. 4B shows that the signal
intensity observed when using an ECL solution contain-
ing 2 mM of 4IPBA is comparable to the one resulting
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the higher background chemiluminescence, using 4IP
instead of 4IPBA does not offer an advantage.
3.6. The optimised 4IPBA–ECL solution shows higher
signal intensity than commercial ECL solutions and has
a lower background than pCA–ECL and 4IP–ECL
It remained to be tested if a 4IPBA solution
containing all constituents in the optimal concentrations
as determined from the individual optimisations would
lead to a superior ECL solution. Western blots of lysates
from 2C4 and U4C cells were detected with two
commercial (Com1 and Com2) and two alternative ECLFig. 5. The optimised 4IPBA–ECL solution shows higher signal intensity th
ECL and 4IP–ECL. (A) Identical Western blots of lysates from 2C4 and U4
chemiluminescence was observed after incubation with a number of ECL
according to the manufacturers' protocols. The self made pCA– and 4IP–E
2.6 mM hydrogenperoxide and either 0.4 mM pCA or 0.4 mM 4IP. The compo
pH 8.8, 1.25 mM luminol, 5.3 mM hydrogenperoxide and 2 mM 4IPBA. Chem
detection system from Intas or for a different series of Western blots by film
were chosen so that signal strength and the different background chemilumin
2 min; long exposure Chemi Lux: 10 min; short exposure film: 15 s; long e
(MAB1501, Chemicon) or anti-ICAM1 (G5, Santa Cruz Biotech.) antibodie
solutions described in (A). Exposure times were 1 min for the anti-actin- ansolutions (pCA and 4IP) as well as with the now
optimised 4IPBA–ECL solution. The pCA–ECL and
4IP–ECL solution contained 100 mM Tris/HCl pH 8.8,
2.5 mM luminol, 2.6 mM hydrogenperoxide and
0.4 mM pCA or 4IP. The optimised 4IPBA–ECL
solution contained 100 mM Tris/HCl pH 8.8, 1.25 mM
luminol, 5.3 mM hydrogenperoxide and 2 mM 4IPBA.
In the Western blot detection with the Jak1 primary
antibody, the latter solution generated a significantly
stronger specific signal than the other ECL solutions
(Fig. 5A). The signal also remained the most intense one
over time (data not shown). Upon longer exposure, the
background chemiluminescence was weak compared to
the other non-commercial ECL solutions (Fig. 5A). Thean commercial ECL solutions and has a lower background than pCA–
C cells were detected with a primary antibody against Jak1. Enhanced
solutions. Commercial ECL solutions Com1 and Com2 were used
CL solutions contained 100 mM Tris/HCl pH 8.8, 2.5 mM luminol,
sition of the optimised 4IPBA–ECL was as follows: 100 mM Tris/HCl
iluminescence was observed for one experiment using the Chemi Lux
detection (Hyperfilm-ECL, Amersham Biosciences). Detection times
escence of the solutions became apparent (short exposure Chemi Lux:
xposure film: 5 min). (B) Western blots were detected with anti-actin
s. ECL detection was performed with the same non-commercial ECL
d 2 min for the anti-ICAM-detection.
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ECL signals were detected on film (Fig. 5A).
Also when using other primary antibodies, e.g. anti-
actin or anti-ICAM1, the optimised 4IPBA solution
generated very strong signals compared to the other non-
commercial ECL solutions (Fig. 5B). Interestingly, we
observed that ICAM1 levels are reduced in U4C cells that
do not express Jak1. As inducible ICAM-1 expression is
known to depend on Jak/STAT signal transduction, e.g.
after IFNγ-stimulation (Walter et al., 1997), it is
conceivable that low-level Jak/STAT signalling (possibly
by an autocrine stimulation) may also crucially contribute
to the constitutive expression of ICAM-1. This will be
addressed in further studies.Fig. 6. The 4IPBA solution is stable over time when stored at 4 °C.
Identical Western blots of lysates from 2C4 and U4C cells were
detected with a primary antibody against Jak1. Enhanced chemilumi-
nescence was observed after incubation with a number of ECL
solutions. The composition of all the final solutions was identical
(100 mM Tris/HCl pH 8.8, 1.25 mM luminol, 5.3 mM hydrogenper-
oxide and 2 mM 4IPBA). One solution has been stored either at room
temperature (RT), at 4 °C or at −20 °C for one month. The solutions
were stored without addition of 5.3 mM hydrogenperoxide which was
added fresh just before detection. Two other solutions were freshly
prepared from stocks. One was prepared from fresh stocks (Stock A).
The other was prepared from stock solutions stored at room
temperature for 1 month (Stock B). Chemiluminescence was observed
using the Chemi Lux detection system from Intas. Detection times
were chosen so that the signal strength and the different background
chemiluminescence of the three solutions became apparent (short
exposure: 1 min; long exposure: 5 min).Moreover, we have also optimised the pCA protocol
(pCA optimised: 100 mM Tris/HCl pH 8.8, 2.5 mM
luminol, 2.6 mM hydrogenperoxide and 0.2 mM pCA).
This optimised pCA–ECL has a comparable signal
intensity to the optimised 4IPBA–ECL but still shows
higher background chemiluminescence (data not
shown).
3.7. 4IPBA solution is stable over time when stored at
4 °C
The stability of the solutions over time was tested by
leaving the 4IPBA–ECL-solution at room temperature
(RT), at 4 °C or at −20 °C for one month. These
solutions were tested in Western blot detections in
comparison to solutions that were freshly prepared from
stocks: either from freshly made ones (stock A) or from
stocks which had been prepared one month ago and
stored at room temperature (stock B). All the solutions
generated signals of comparable strength in the Western
blot detection (Fig. 6). We conclude that the solution is
stable under all conditions tested for one month
minimum. The background chemiluminescence, how-
ever, was highest in the solution stored for one month at
room temperature followed by the solution stored at
4 °C (Fig. 6, lower panel). Thus, for optimal results we
recommend the fresh preparation of the solution from
stocks.
4. Concluding remarks
We have presented an effective, optimised protocol
for Western blot detection that offers an excellent
performance at low cost. In a comparison of different
non-commercial ECL-solutions with commercial solu-
tions we have demonstrated the advantages of the
4IPBA–ECL-solution, which combines better sensitiv-
ity and low background chemiluminescence. This ECL
solution is useful in Western blot detections of total cell
lysates, where background chemiluminescence is often
high. Of note, the pCA– and 4IPBA–ECL-solutions
can, after the addition of hydrogenperoxide, be used
several times to detect Western blots during the same
day but should not be used longer (just as the
commercial solutions). The alternative ECL solutions
do not contain chemicals which harm the blots: We
regularly redetect Western blots after stripping for up to
five times with these reagents (data not shown). Due to
the strong signals and the low background of the
4IPBA–ECL solution, the primary and secondary
antibodies used for detection can also be used at lower
concentrations. This again reduces the cost and may
19C. Haan, I. Behrmann / Journal of Immunological Methods 318 (2007) 11–19help to save resources in the case of limited stocks of
antibody. Furthermore, “self made” ECL solutions allow
maximum flexibility: For a given antibody one can
easily optimise conditions if this is necessary. The novel
protocol is of special interest in applications where
lowest possible background is needed.
Acknowledgement
We are grateful to Dr. I. M. Kerr (Cancer Research
UK, London) for providing 2C4 and U4C cells. This
work has been supported by a grant from the University
of Luxembourg, project R1F105L01.
References
Behrmann, I., Smyczek, T., Heinrich, P.C., Schmitz-Van de Leur, H.,
Komyod, W., Giese, B., Müller-Newen, G., Haan, S., Haan, C.,
2004. Janus kinase (Jak) subcellular localization revisited: the
exclusive membrane localization of endogenous Janus kinase 1 by
cytokine receptor interaction uncovers the Jak.receptor complex to
be equivalent to a receptor tyrosine kinase. J. Biol. Chem. 279,
35486.
Handley, R.S., Eickholt, R.A., Schaap,A.P.,Akhavan-Tafti, H., 2004.On
the mechanism of arylboronic acid “enhancement” of peroxidase-
catalyzed reactions. Abstract of the 13th International Symposium on
Bioluminescence & Chemiluminescence. Luminescence 19, 144.
Heinrich, P.C., Behrmann, I., Haan, S., Hermanns, H.M., Müller-
Newen, G., Schaper, F., 2003. Principles of interleukin (IL)-6-type
cytokine signalling and its regulation. Biochem. J. 374, 1.
Ilyina, A.D., Mauricio, B.J.E., Sifuentes, S.I.P., Martinez, H.J.L.,
Bogatcheva, E.S., Romero, G.J., Rodriguez, M.J., 2000. Behavior
of enhanced chemiluminescence peroxidase-catalyzed peroxida-
tion of luminol in the system of surfactant–water–organic solvent.
Mosc. Univ. Chem. Bull. 41, 109.
Iwata, R., Ito, H., Hayashi, T., Sekine, Y., Koyama, N., Yamaki, M.,
1995. Stable and general-purpose chemiluminescent detection
system for horseradish peroxidase employing a thiazole compound
enhancer and some additives. Anal. Biochem. 231, 170.
Ji, X., Kricka, L.J., 1996. Effect of polymers on enhanced
chemiluminescent assays for peroxidase and peroxidase labels.
J. Biolumin. Chemilumin. 11, 303.Kohlhuber, F., Rogers, N.C., Watling, D., Feng, J., Guschin, D.,
Briscoe, J., Witthuhn, B.A., Kotenko, S.V., Pestka, S., Stark, G.R.,
Ihle, J.N., Kerr, I.M., 1997. A JAK1/JAK2 chimera can sustain
alpha and gamma interferon responses. Mol. Cell. Biol. 17, 695.
Kricka, L.J., Cooper, M., Ji, X., 1996a. Synthesis and characterization
of 4-iodophenylboronic acid: a new enhancer for the horseradish
peroxidase-catalyzed chemiluminescent oxidation of luminol.
Anal. Biochem. 240, 119.
Kricka, L.J., Ji, X., Thorpe, G.H., Edwards, B., Voyta, J., Bronstein, I.,
1996b. Comparison of 5-hydroxy-2, 3-dihydrophthalazine-1, 4-
dione and luminol as co-substrates for detection of horseradish
peroxidase in enhanced chemiluminescent reactions. J. Immu-
noass. 17, 67.
Kuroda, N., Kawazoe, K., Nakano, H., Wada, M., Nakashima, K.,
1999. New phenylboronic acid derivatives as enhancers of the
luminol-H(2)O(2)-horseradish peroxidase chemiluminescence re-
action. Luminescence 14, 361.
Kuroda, N., Murasaki, N., Wada, M., Nakashima, K., 2001.
Application of an enhanced luminol chemiluminescence reaction
using 4-[4,5-di(2-pyridyl)-1H-imidazol-2-yl]phenylboronic acid to
photographic detection of horseradish peroxidase on a membrane.
Luminescence 16, 167.
Motsenbocker, M.A., Kondo, K., 1994. Improvements to enhanced
horseradish peroxidase detection sensitivity. J. Biolumin. Chemi-
lumin. 9, 15.
Rehm, H., 2002. Der Experimentator: Proteinbiochemie/Proteomics.
Spektrum Akad. Verlag, Heidelberg.
Thorpe, G.H., Kricka, L.J., Moseley, S.B., Whitehead, T.P., 1985.
Phenols as enhancers of the chemiluminescent horseradish peroxi-
dase-luminol-hydrogen peroxide reaction: application in lumines-
cence-monitored enzyme immunoassays. Clin. Chem. 31, 1335.
Walter, M.J., Look, D.C., Tidwell, R.M., Roswit, W.T., Holtzman, M.J.,
1997. Targeted inhibition of interferon-gamma-dependent intercel-
lular adhesion molecule-1 (ICAM-1) expression using dominant-
negative Stat1. J. Biol. Chem. 272, 28582.
Yeh, H.C., Lin, W.Y., 2002. Enhanced chemiluminescence for the
oxidation of luminol with m-chloroperoxybenzoic acid catalyzed
by microperoxidase 8. Anal. Bioanal. Chem. 372, 525.
Yeh, T.C., Pellegrini, S., 1999. The Janus kinase family of protein
tyrosine kinases and their role in signaling. Cell. Mol. Life Sci. 55,
1523.
